For kidney transplant recipients with type 2 diabetes, use of glucagon-like peptide-1 receptor agonists was associated with ...

With this year's US Food and Drug Administration approval of the Supera ® peripheral stent system (Abbott Vascular), interventionists across the United States have had the chance to use a truly unique ...